170 related articles for article (PubMed ID: 36353544)
21. Microbiota unbalance in relation to high-risk human papillomavirus cervical infection.
Gomez Cherey JF; Payalef SN; Fleider L; Reyes AP; Maldonado VA; Losada MO; Chen X; Cardinal LH; Wang Y; Tatti SA; Perazzi BE
Int J Gynecol Cancer; 2023 Apr; 33(4):482-488. PubMed ID: 36604120
[TBL] [Abstract][Full Text] [Related]
22. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
[TBL] [Abstract][Full Text] [Related]
23. Exploring the Association Between Cervical Microbiota and HR-HPV Infection Based on 16S rRNA Gene and Metagenomic Sequencing.
Fang B; Li Q; Wan Z; OuYang Z; Zhang Q
Front Cell Infect Microbiol; 2022; 12():922554. PubMed ID: 35800388
[TBL] [Abstract][Full Text] [Related]
24. Non-16/18 high-risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL.
Lyons YA; Kamat AA; Zhou H; Mody DR; Schwartz MR; Hobday C; Ge Y
Cancer Cytopathol; 2015 Jul; 123(7):435-42. PubMed ID: 25903015
[TBL] [Abstract][Full Text] [Related]
25. Microbiota and HPV: The role of viral infection on vaginal microbiota.
Santella B; Schettino MT; Franci G; De Franciscis P; Colacurci N; Schiattarella A; Galdiero M
J Med Virol; 2022 Sep; 94(9):4478-4484. PubMed ID: 35527233
[TBL] [Abstract][Full Text] [Related]
26. Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis.
Lin W; Zhang Q; Chen Y; Dong B; Xue H; Lei H; Lu Y; Wei X; Sun P
Sci Rep; 2022 Feb; 12(1):2812. PubMed ID: 35181685
[TBL] [Abstract][Full Text] [Related]
27. Does the vaginal microbiota play a role in the development of cervical cancer?
Kyrgiou M; Mitra A; Moscicki AB
Transl Res; 2017 Jan; 179():168-182. PubMed ID: 27477083
[TBL] [Abstract][Full Text] [Related]
28. The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis.
Borgogna JC; Shardell MD; Santori EK; Nelson TM; Rath JM; Glover ED; Ravel J; Gravitt PE; Yeoman CJ; Brotman RM
BJOG; 2020 Jan; 127(2):182-192. PubMed ID: 31749298
[TBL] [Abstract][Full Text] [Related]
29. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
Gu L; Hong Z; Gao H; Qiu L; Di W
Cytopathology; 2019 Jul; 30(4):419-425. PubMed ID: 31069857
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the efficacy and safety of 5-aminolevulinic acid-mediated photodynamic therapy in women with high-risk HPV persistent infection after cervical conization.
Wang L; Liu X; Zhang J; Huang Y; Liu Y; Jia L; Zhang Y; Jia L
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103144. PubMed ID: 36210038
[TBL] [Abstract][Full Text] [Related]
31. Cervicovaginal microbiota significantly changed for HPV-positive women with high-grade squamous intraepithelial lesion.
Guo C; Dai W; Zhou Q; Gui L; Cai H; Wu D; Hou J; Li C; Li S; Du H; Wu R
Front Cell Infect Microbiol; 2022; 12():973875. PubMed ID: 35992171
[TBL] [Abstract][Full Text] [Related]
32. The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis.
Liu Y; Li T; Guo R; Chen T; Wang S; Wu D; Li J; Liu Z; Zhao Y; Yin J; Qin J; Sun L; Chen W
J Med Virol; 2023 Mar; 95(3):e28595. PubMed ID: 36811337
[TBL] [Abstract][Full Text] [Related]
33. Types and viral load of human papillomavirus, and vaginal microbiota in vaginal intraepithelial neoplasia: a cross-sectional study.
Zhou FY; Zhou Q; Zhu ZY; Hua KQ; Chen LM; Ding JX
Ann Transl Med; 2020 Nov; 8(21):1408. PubMed ID: 33313153
[TBL] [Abstract][Full Text] [Related]
34. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
35. Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection.
Wei ZT; Chen HL; Wang CF; Yang GL; Han SM; Zhang SL
Front Public Health; 2020; 8():587298. PubMed ID: 33490017
[TBL] [Abstract][Full Text] [Related]
36. Cervical Intraepithelial Neoplasia 3 (Cervical Intraepithelial Neoplasia 3/High-Grade Squamous Intraepithelial Lesion) in Human Papillomavirus-Vaccinated Women-Results From a Tertiary Referral Center.
Domröse CM; Wieland U; Pilch H; Einzmann T; Schömig-Markiefka B; Mallmann P; Silling S; Mallmann MR
J Low Genit Tract Dis; 2022 Apr; 26(2):122-126. PubMed ID: 35019900
[TBL] [Abstract][Full Text] [Related]
37. Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression.
Liu H; Liang H; Li D; Wang M; Li Y
Microbiol Spectr; 2022 Oct; 10(5):e0015122. PubMed ID: 36036584
[TBL] [Abstract][Full Text] [Related]
38. Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2.
Berggrund M; Gustavsson I; Aarnio R; Lindberg JH; Sanner K; Wikström I; Enroth S; Bunikis I; Olovsson M; Gyllensten U
Virol J; 2020 Oct; 17(1):147. PubMed ID: 33028395
[TBL] [Abstract][Full Text] [Related]
39. Vaginal Microbiota and Cytokine Microenvironment in HPV Clearance/Persistence in Women Surgically Treated for Cervical Intraepithelial Neoplasia: An Observational Prospective Study.
Caselli E; D'Accolti M; Santi E; Soffritti I; Conzadori S; Mazzacane S; Greco P; Contini C; Bonaccorsi G
Front Cell Infect Microbiol; 2020; 10():540900. PubMed ID: 33251154
[TBL] [Abstract][Full Text] [Related]
40. The effect of aminolevulinic acid hydrochloride topical powder photodynamic therapy versus nocardia rubra cell wall skeleton and observers group in the treatment of cervical low-grade squamous intraepithelial lesions with human papillomavirus infection: A non-randomized study, controlled pilot study.
Jiang S; Nan X; Pan X; Zhang J; Tang L; Gong H
Medicine (Baltimore); 2023 Jul; 102(27):e34302. PubMed ID: 37417604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]